Prognostic Significance of Dynamic Free T3 Changes in Critically Ill Patients

Area of Science:

• Endocrinology
• Critical Care Medicine

Background:

• Non-thyroidal illness syndrome is common in critically ill patients.
• The prognostic significance of dynamic thyroid function test changes is not fully understood.

Purpose of the Study:

• To assess if serial thyroid-stimulating hormone (TSH) and free triiodothyronine (FT3) measurements improve 30-day mortality prediction in ICU patients.
• To determine if dynamic FT3 changes offer additional value beyond established severity scores.

Main Methods:

• Retrospective observational study of 74 adult ICU patients with serial TSH and FT3 measurements.
• Analysis included demographic data, comorbidities, APACHE II, SOFA, mNUTRIC scores, and routine labs.
• Logistic regression and ROC curves evaluated the predictive performance of FT3 kinetics and severity scores for 30-day mortality.

Main Results:

• Non-survivors exhibited higher severity scores and lower albumin, lymphocyte counts, and second FT3 levels.
• Baseline FT3 and TSH were not predictive, but subsequent FT3 and ΔT3 (FT3 change) were significant predictors.
• A model combining APACHE II and ΔT3 demonstrated superior discrimination (AUC: 0.921) compared to APACHE II alone (AUC: 0.861).

Conclusions:

• Dynamic FT3 kinetics, particularly a decline within 72 hours, provide incremental prognostic value for 30-day mortality in critically ill adults.
• Serial FT3 monitoring can identify high-risk patients with failing endocrine adaptation to critical illness.
• Early detection of FT3 decline aids in risk stratification and patient management.